These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21291359)

  • 21. Transplantation for stroke.
    Roitberg B
    Neurol Res; 2004 Apr; 26(3):256-64. PubMed ID: 15142317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canadian Association of Neuroscience review: axonal regeneration in the peripheral and central nervous systems--current issues and advances.
    Fenrich K; Gordon T
    Can J Neurol Sci; 2004 May; 31(2):142-56. PubMed ID: 15198438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter repair: skin-derived precursors as a source of myelinating cells.
    Biernaskie J; Miller FD
    Can J Neurol Sci; 2010 Sep; 37 Suppl 2():S34-41. PubMed ID: 21246933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1.
    Weidner N; Blesch A; Grill RJ; Tuszynski MH
    J Comp Neurol; 1999 Nov; 413(4):495-506. PubMed ID: 10495438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ; Tator CH
    Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory ensheathing cells exhibit unique migratory, phagocytic, and myelinating properties in the X-irradiated spinal cord not shared by Schwann cells.
    Lankford KL; Sasaki M; Radtke C; Kocsis JD
    Glia; 2008 Nov; 56(15):1664-78. PubMed ID: 18551623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction and adhesive mechanisms between axon and Schwann cell during central and peripheral nerve regeneration.
    Dezawa M
    Kaibogaku Zasshi; 2000 Jun; 75(3):255-65. PubMed ID: 10920603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal age influences the response to neurite outgrowth inhibitory activity in the central and peripheral nervous systems.
    Ng WP; Lozano AM
    Brain Res; 1999 Jul; 836(1-2):49-61. PubMed ID: 10415404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus.
    Kanno H; Pearse DD; Ozawa H; Itoi E; Bunge MB
    Rev Neurosci; 2015; 26(2):121-8. PubMed ID: 25581750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of olfactory ensheathing cells for cell-based therapy in spinal cord injury.
    Radtke C; Sasaki M; Lankford KL; Vogt PM; Kocsis JD
    J Rehabil Res Dev; 2008; 45(1):141-51. PubMed ID: 18566933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory ensheathing cells: bridging the gap in spinal cord injury.
    Bartolomei JC; Greer CA
    Neurosurgery; 2000 Nov; 47(5):1057-69. PubMed ID: 11063098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural precursor cells: applications for the study and repair of the central nervous system.
    Fisher LJ
    Neurobiol Dis; 1997; 4(1):1-22. PubMed ID: 9258907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult Stem Cell-Based Strategies for Peripheral Nerve Regeneration.
    De la Rosa MB; Kozik EM; Sakaguchi DS
    Adv Exp Med Biol; 2018; 1119():41-71. PubMed ID: 30151648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olfactory ensheathing cells: characteristics, genetic engineering, and therapeutic potential.
    Ruitenberg MJ; Vukovic J; Sarich J; Busfield SJ; Plant GW
    J Neurotrauma; 2006; 23(3-4):468-78. PubMed ID: 16629630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olfactory mucosa: a rich source of cell therapy for central nervous system repair.
    Duan D; Lu M
    Rev Neurosci; 2015; 26(3):281-93. PubMed ID: 25781675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural stem cell transplantation in an animal model of traumatic brain injury.
    Thomaidou D
    Methods Mol Biol; 2014; 1210():9-21. PubMed ID: 25173157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do olfactory glia have advantages over Schwann cells for CNS repair?
    Franklin RJ; Barnett SC
    J Neurosci Res; 1997 Dec; 50(5):665-72. PubMed ID: 9418955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remyelination: cellular and gene therapy.
    Billinghurst LL; Taylor RM; Snyder EY
    Semin Pediatr Neurol; 1998 Sep; 5(3):211-28. PubMed ID: 9777679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of experimental cell replacement approaches to spinal cord injury.
    Eftekharpour E; Karimi-Abdolrezaee S; Fehlings MG
    Neurosurg Focus; 2008; 24(3-4):E19. PubMed ID: 18341395
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.